Ramipril and Application site rash - a phase IV clinical study of FDA data

Summary:

Application site rash is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 60+ old, also take Simvastatin, and have Pain.

The phase IV clinical study analyzes which people have Application site rash when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Application site rash?

Application site rash is found to be associated with 401 drugs and 629 conditions by eHealthMe. Check the latest studies of Application site rash.

On Jul, 08, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 14 people (0.01%) have Application site rash.

Could Ramipril cause Application site rash?

Among these 14 people:

What is the gender of people who have Application site rash when taking Ramipril? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Application site rash when taking Ramipril? *

What are other drugs people take besides Ramipril? *

Simvastatin: 3 people, 21.43%
Warfarin Sodium: 2 people, 14.29%
Clopidogrel: 2 people, 14.29%
Amlodipine: 2 people, 14.29%
Carvedilol: 2 people, 14.29%
Pantoprazole: 2 people, 14.29%
Colecalciferol: 2 people, 14.29%
Centrum Silver: 2 people, 14.29%
Gabapentin: 1 person, 7.14%
Fentanyl Transdermal System: 1 person, 7.14%

What are other side effects people have besides Application site rash? *

Application Site Erythema (redness of the skin at application site): 7 people, 50.00%
Application Site Pruritus (application site severe itching of the skin): 4 people, 28.57%
Application Site Pain: 3 people, 21.43%
Application Site Hypersensitivity: 2 people, 14.29%
Application Site Scab (hard coating on the skin formed at application site): 2 people, 14.29%
Application Site Irritation: 2 people, 14.29%
Drug Ineffective: 2 people, 14.29%
Rashes (redness): 2 people, 14.29%
Application Site Exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface): 1 person, 7.14%
Application Site Papules (solid elevation of skin with no visible fluid at application site): 1 person, 7.14%

What are the existing conditions these people have? *

Pain: 2 people, 14.29%
Thyroid Diseases: 1 person, 7.14%
Thyroid Cancer: 1 person, 7.14%
Pelvic Pain: 1 person, 7.14%
Incontinence (lack of moderation or self-control): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Hair Loss: 1 person, 7.14%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 7.14%
Diabetes: 1 person, 7.14%
Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Application site rash?

- Check whether Application site rash is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site rash:

Application site rash (401 drugs)

Browse all the conditions that are associated with Application site rash:

Application site rash (629 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.